IPO Boutique

Crinetics Pharmaceuticals, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Crinetics Pharmaceuticals, Inc. , and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Crinetics Pharmaceuticals, Inc. CRNX -
NASDAQ
$15.00-$17.00 $17.00 $19.256.0 million7/18/2018
J.P. Morgan, Leerink Partners, Piper Jaffray
Co-Manager(s):
Health Care
Filing(s):

Filed 2018-06-22
Terms Added 2018-07-09



Crinetics Pharmaceuticals, Inc. Quote & Chart - Click for current quote - CRNX

About Crinetics Pharmaceuticals, Inc. (adapted from Crinetics Pharmaceuticals, Inc. prospectus):
They are a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "CRNX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved